Stockscreener 앱 받기
36.14
1.20%
0.43
전일 마감가:
$35.71
열려 있는:
$36.8
하루 거래량:
1.21M
Relative Volume:
1.11
시가총액:
$2.26B
수익:
-
순이익/손실:
$-230.66M
주가수익비율:
-8.6579
EPS:
-4.1742
순현금흐름:
$-148.12M
1주 성능:
+6.39%
1개월 성능:
+3.20%
6개월 성능:
+37.00%
1년 성능:
+923.80%
1일 변동 폭
$35.18
$37.50
1주일 범위
$32.55
$37.50
52주 변동 폭
$3.43
$47.84
Kodiak Sciences Inc Stock (KOD) Company Profile
명칭
Kodiak Sciences Inc
전화
650-281-0850
주소
1250 PAGE MILL RD, PALO ALTO, CA
Compare KOD vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
36.14 | 2.26B | 0 | -230.66M | -148.12M | -4.1742 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-11 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-10-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-09-25 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2025-09-22 | 개시 | Jefferies | Buy |
| 2025-08-14 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-12-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-09-05 | 개시 | H.C. Wainwright | Neutral |
| 2023-12-11 | 재개 | Goldman | Sell |
| 2023-11-17 | 업그레이드 | CapitalOne | Equal Weight → Overweight |
| 2023-07-27 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-07-25 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2023-07-25 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-07-24 | 다운그레이드 | CapitalOne | Overweight → Equal Weight |
| 2023-07-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-11-15 | 개시 | CapitalOne | Overweight |
| 2022-08-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-02-24 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2022-02-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-05-11 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2021-03-12 | 개시 | Evercore ISI | Outperform |
| 2021-03-01 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2021-02-17 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2021-01-25 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-12-11 | 개시 | Citigroup | Neutral |
| 2020-11-30 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-11-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-31 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-03 | 개시 | Goldman | Buy |
| 2020-02-18 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-02-06 | 개시 | SunTrust | Buy |
| 2020-01-08 | 개시 | ROTH Capital | Buy |
| 2020-01-03 | 개시 | Jefferies | Buy |
| 2019-12-24 | 개시 | JP Morgan | Overweight |
| 2019-10-15 | 재확인 | Chardan Capital Markets | Buy |
| 2019-02-20 | 개시 | Chardan Capital Markets | Buy |
| 2018-10-29 | 개시 | Barclays | Overweight |
| 2018-10-29 | 개시 | BofA/Merrill | Buy |
| 2018-10-29 | 개시 | Morgan Stanley | Overweight |
모두보기
Kodiak Sciences Inc 주식(KOD)의 최신 뉴스
Kodiak Sciences Inc (KOD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Kodiak Sciences Inc (KOD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Kodiak Sciences Inc (KOD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Kodiak Sciences Inc (KOD) Institutional Confidence - TradingKey
Kodiak Sciences Inc (KOD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Kodiak Sciences Inc (KOD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Kodiak Sciences Inc (KOD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Kodiak Sciences Inc (KOD) Valuation: PE, PB & Fair Value Analysis - TradingKey
KOD Q1 2026 Earnings: Narrower-Than-Expected Loss as Pipeline Progress Temps Market SkepticismEarnings Decline Risk - newsline.com
Kodiak Sciences Inc Stock (US50012K1051): Quiet-day stock in focus after no fresh trigger was verifi - AD HOC NEWS
Kodiak Sciences: Clinical Redemption Is Turning Into Platform Leverage (NASDAQ:KOD) - Seeking Alpha
Kodiak Sciences Inc (KOD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
KOD News | KODIAK SCIENCES INC (NASDAQ:KOD) - ChartMill
Kodiak Sciences (KOD) Edges Higher: Biotech Momentum Builds at $34.55ATR Stop - newsline.com
Kodiak stock rises 35% in 3 months: Here's what you need to know - MSN
Kodiak Sciences Inc. - MLQ.ai
Kodiak Sciences Zenkuda Trial Win Puts Cash Needs And Growth In Focus - Sahm
Kodiak Sciences (KOD) Is Down 15.4% After Strong Zenkuda GLOW2 Data And Accelerated Filing Plans - Yahoo Finance
Kodiak Sciences CFO John Borgeson sold $1.02 million in NASDAQ:KOD shares By Investing.com - Investing.com South Africa
Kodiak Sciences CFO John Borgeson sold $1.02 million in NASDAQ:KOD shares - Investing.com Nigeria
Kodiak (KOD) CFO sells 30,000 shares under 10b5-1 trading plan - Stock Titan
Why Did KOD Stock Surge To A Four-Year High Today? - Stocktwits
Kodiak Sciences Inc. (KOD) Presents at Jefferies Global Healthcare Conference 2026Slideshow - Seeking Alpha
Kodiak Sciences Inc. Files Form 8-K with SEC Detailing Company and Stock Information (June 2026) - Minichart
Kodiak Sciences Stockholders Back Directors and Governance Proposals - TipRanks
Kodiak Sciences (NASDAQ: KOD) 2026 meeting approves all proposals - Stock Titan
KOD (NASDAQ: KOD) scheduled sale of 30,000 shares after option exercise - Stock Titan
Kodiak Stock Rises 35% in 3 Months: Here's What You Need to Know - The Globe and Mail
Kodiak Sciences CEO to present at 2026 Jefferies Global Healthcare Conference on June 4 - Pluang
Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference - 富途牛牛
Kodiak Sciences CEO to speak at 2026 Jefferies healthcare event - Stock Titan
Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally - AOL.com
Kodiak Sciences Falls Before Holiday Pause With Eyes on Drug Update - Bez Kabli
KOD Technical Analysis | Trend, Signals & Chart Patterns | KODIAK SCIENCES INC (NASDAQ:KOD) - ChartMill
Kodiak Sciences Inc stock (US50012K1051): earnings loss widens as biotech pushes retina pipeline - AD HOC NEWS
Kodiak Sciences Inc stock (US50012K1051): what’s behind the latest volatility after eye disease se - AD HOC NEWS
Boxer Capital Management Boosts Kodiak Sciences Holdings in Q1 2026News and Statistics - IndexBox
Kodiak Sciences Inc stock (US50012K1051): Investors eye eye-disease pipeline after latest company up - AD HOC NEWS
Kodiak Sciences stock hits 52-week highhere's why - MSN
Kodiak Sciences (KOD) price target increased by 16.91% to 66.30 - MSN
Sirenia Capital (KOD) and Alex Silverstein report 3,495,000 shares (5.7%) - Stock Titan
Kodiak Sciences stock is surging Friday: What's driving the action? - MSN
Kodiak Sciences stock (US50012K1051): Q4 2025 earnings miss sparks investor focus - AD HOC NEWS
Kodiak Sciences (KOD) up 2% since last earnings report: Can it continue? - MSN
J.P. Morgan Maintains Kodiak Sciences(KOD.US) With Buy Rating, Cuts Target Price to $56 - Moomoo
Number of shareholders of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Analysts Offer Insights on Healthcare Companies: Kodiak Sciences (KOD), IN8bio (INAB) and Ultragenyx Pharmaceutical (RARE) - The Globe and Mail
Chardan Capital upgrades Kodiak Sciences (KOD) - MSN
TradingKey - TradingKey
KOD Upgraded by Chardan Capital -- Price Target Raised to $61.00 - GuruFocus
Kodiak Sciences Inc (KOD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
1.44%
자본화:
|
볼륨(24시간):